Prurigo Nodularis clinical trials at UC Health
1 research study open to eligible people

• A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Prurigo Nodularis

  open to eligible people ages 18-75

  Study of the efficacy, safety, tolerability, pharmacokinetics (PK) and immunogenicity of KPL-716 in subjects with prurigo nodularis.

  at UCSF

Last updated: November 15, 2019